Domestic New Crown Prevention + Treatment Research Press the Accelerator Key: Two mRNA New Crown Vaccines Enter Clinical Phase III Clinical News of Domestic New Crown Oral Drugs

  • Post date April 7, 2022 — 23:49 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000925 002014 002486 002786 002940 300122 300142 300357 300601 Bank Of China China Securities Chongqing Zhifei Biological Products Huangshan Novel Jiangsu Hengrui Medicine Shanghai Challenge Textile Company Limited Shanghai Fosun Pharmaceutical Shenzhen Kangtai Biological Products Shenzhen Silver Basis Technology Unittec Walvax Biotechnology Zhejiang Anglikang Pharmaceutical Zhejiang Wolwo Bio-Pharmaceutical Witness Strategy, Marketing Annual, Special Corporate Meeting Annual Report Research, Development Health, Beauty Product Pharmaceutical Insurance Gold, Precious Material Market, Exchange Securities Cancer Epidemic Obesity Medicine Vaccines Therapy Health Insurance Workplace Health, Safety Food, Drink Enthusiasm House, Home Small, Medium Enterprise Pandemic Economy, Business, Finance Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data